BR112020002619A2 - nanoemulsão de ácidos graxos iodados para imageamento de ct - Google Patents

nanoemulsão de ácidos graxos iodados para imageamento de ct Download PDF

Info

Publication number
BR112020002619A2
BR112020002619A2 BR112020002619-0A BR112020002619A BR112020002619A2 BR 112020002619 A2 BR112020002619 A2 BR 112020002619A2 BR 112020002619 A BR112020002619 A BR 112020002619A BR 112020002619 A2 BR112020002619 A2 BR 112020002619A2
Authority
BR
Brazil
Prior art keywords
vivo
contrast agent
nanoemulsion
imaging method
fatty acids
Prior art date
Application number
BR112020002619-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Laurent Vinet
Andrej Babic
Eric Allemann
Original Assignee
University Of Geneva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Geneva filed Critical University Of Geneva
Publication of BR112020002619A2 publication Critical patent/BR112020002619A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicinal Preparation (AREA)
BR112020002619-0A 2017-08-07 2018-07-27 nanoemulsão de ácidos graxos iodados para imageamento de ct BR112020002619A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17185185.0 2017-08-07
EP17185185 2017-08-07
PCT/EP2018/070501 WO2019030024A1 (en) 2017-08-07 2018-07-27 NANOEMULSION OF IODIZED FATTY ACIDS FOR COMPUTER-ASSISTED TOMOGRAPHY (CT) IMAGING

Publications (1)

Publication Number Publication Date
BR112020002619A2 true BR112020002619A2 (pt) 2020-07-28

Family

ID=59564118

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020002619-0A BR112020002619A2 (pt) 2017-08-07 2018-07-27 nanoemulsão de ácidos graxos iodados para imageamento de ct

Country Status (9)

Country Link
US (1) US11654202B2 (https=)
EP (1) EP3664855A1 (https=)
JP (1) JP7210542B2 (https=)
CN (1) CN111194225B (https=)
AU (1) AU2018314406B2 (https=)
BR (1) BR112020002619A2 (https=)
CA (1) CA3072282A1 (https=)
EA (1) EA202090139A1 (https=)
WO (1) WO2019030024A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118178688A (zh) 2019-02-13 2024-06-14 日内瓦大学 用于恶病质的检测的ct造影剂
CA3190518A1 (en) * 2020-08-06 2022-02-10 Adiposs SA Pet-ct imaging methods, contrast agents and pharmaceutical compositions for use in said imaging methods
CN112933246A (zh) * 2020-12-17 2021-06-11 太阳雨林（厦门）生物医药有限公司 一种可显影的油制剂及其制备方法
JP2024530159A (ja) * 2021-08-02 2024-08-16 マイクロベンション インコーポレイテッド 医療画像用ヨウ素化脂肪酸
WO2023073195A1 (en) 2021-10-28 2023-05-04 Adiposs SA Emulsions, compositions for emulsions, methods for making the same and uses thereof
WO2025079088A1 (en) * 2023-10-11 2025-04-17 Bioroot Exploration India Private Limited A contrast agent for computed tomography and process of preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258172A (en) * 1983-12-29 1993-11-02 Rubin Daniel L Iodinated aliphatic emulsions for X-ray contrast
ATE89171T1 (de) 1987-06-11 1993-05-15 Kabi Pharmacia Ab Jod enthaltende emulsion.
US5861367A (en) 1993-08-04 1999-01-19 Colgate Palmolive Company Cleaning and disinfecting composition in microemulsion/liquid crystal form comprising aldehyde and mixture of partially esterified, fully esterified and non-esterified polyhydric alcohols
FR2736549B1 (fr) * 1995-07-11 1997-10-10 Louis Jung Esters d'acides gras iodes, acides gras iodes et leurs derives, obtenus par iodohydrination faisant intervenir des derives alkylsilyles avec des iodures alcalins et leurs activites pharmacologiques
DE19936727A1 (de) 1999-08-06 2001-02-08 Henkel Kgaa Niotensidbasiertes wäßriges mehrphasiges Reinigungsmittel
CA2534426A1 (en) * 2003-08-08 2005-02-17 Barnes-Jewish Hospital Emulsion particles for imaging and therapy and methods of use thereof
GB0408684D0 (en) 2004-04-19 2004-05-19 Guy S And St Thomas Hospital N Diagnostic method
SG10201505948VA (en) 2004-12-13 2015-09-29 Amylin Pharmaceuticals Llc Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same
EP1989179B1 (en) 2006-02-15 2011-01-26 Ge Healthcare As Contrast agents
US20080319315A1 (en) 2007-06-07 2008-12-25 Beth Israel Deaconess Medical Center Method of reducing interferences in positron emission tomography
WO2012080279A1 (en) 2010-12-17 2012-06-21 Universite De Strasbourg Radiopaque iodinated products intended for use medical imaging and their methods of preparation
KR101263733B1 (ko) 2011-03-22 2013-05-14 한국과학기술연구원 리피오돌을 함유하는 컴퓨터 단층촬영용 혈관 조영제
CN102166365B (zh) 2011-04-25 2012-10-24 东南大学 一种多模态碘油纳米乳造影剂的制备方法
DE102012204378A1 (de) 2012-03-20 2013-09-26 Bernd Schwegmann Gmbh & Co. Kg Reinigungsmittel auf Mikroemulsionsbasis
US10786583B2 (en) 2013-09-30 2020-09-29 B.Braun Melsungen Ag Pre-saturation of the liver and subsequent administration of the contrast agent
US10668161B2 (en) 2014-02-24 2020-06-02 The Regents Of The University Of California Therapeutic hyperbranched polyglycerol encapsulated biomolecules
US10157462B2 (en) 2016-06-27 2018-12-18 University Of Central Florida Research Foundation, Inc. System and method for image-based quantification of white and brown adipose tissue at the whole-body, organ and body-region levels

Also Published As

Publication number Publication date
US11654202B2 (en) 2023-05-23
CN111194225A (zh) 2020-05-22
WO2019030024A1 (en) 2019-02-14
CA3072282A1 (en) 2019-02-14
EP3664855A1 (en) 2020-06-17
US20210330820A1 (en) 2021-10-28
AU2018314406B2 (en) 2024-08-15
AU2018314406A1 (en) 2020-02-20
CN111194225B (zh) 2023-01-13
JP2020529441A (ja) 2020-10-08
EA202090139A1 (ru) 2020-08-06
JP7210542B2 (ja) 2023-01-23

Similar Documents

Publication Publication Date Title
BR112020002619A2 (pt) nanoemulsão de ácidos graxos iodados para imageamento de ct
US20260007779A1 (en) Ct contrast agent for detection of cachexia
JPH0339045B2 (https=)
JP7818571B2 (ja) Ｐｅｔ－ｃｔ撮像方法、その撮像方法における使用のための造影剤および医薬組成物
US20200268776A1 (en) Emulsion composition for chemoembolization and method for producing same
JP2009023929A (ja) 微小循環構築の血管種別選択的造影剤および造影方法
EA043372B1 (ru) Контрастный агент для компьютерной томографии
US12082918B2 (en) Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(N-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation
AU758913B2 (en) Drugs for therapeutic use enabling nuclear magnetic resonance diagnosis by scalar bond
EA045963B1 (ru) Контрастный агент для кт для детекции кахексии
PT815072E (pt) Agentes de contraste de raios x para a tomografia e a urografia computadorizadas

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]